Couple of nice announcements to end the week.
Question:
Very uncommon for BP to snap any treatment up before phase 2, but being such a massive $$$ space we are currently working in and with no solid tumour treatments going around, how tempting would this sort of information be to a BP?
Would they take a risk with pre clinical data??
They take risk and get it cheap or they wait and potentially pay top dollar, or the treatment becomes available to multi BP through partnerships??
what's more appealing to BP?
Thanks :)
Couple of nice announcements to end the week.Question:Very...
-
- There are more pages in this discussion • 7,135 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
-0.002(3.77%) |
Mkt cap ! $373.3M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.2¢ | 5.0¢ | $669.7K | 13.07M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1074997 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 1209633 | 6 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |